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C6 gliomamodulation of intracellular calcium alters the functional activity of the EAAC1
glutamate transporter in C6 glioma cells. Pre-incubation of C6 glioma cells with the endoplasmic reticulum
Ca2+ ATP pump inhibitor, thapsigargin (10 μM) produced a time-dependent increase in the Vmax for D-[
3H]
aspartate transport that reached a maximum at 15 min (143% of control; Pb0.001) that was accompanied by
increased plasma membrane expression of EAAC1 and was blocked by inhibition of protein kinase C.
Pre-incubation of C6 glioma cells with phorbol myristate-3-acetate (100 nM for 20 min) also caused a
signiﬁcant increase in the Vmax of sodium-dependent D-[3H]aspartate transport (190% of control; Pb0.01). In
contrast, in the absence of extracellular calcium, thapsigargin caused a signiﬁcant inhibition in D-[3H]
aspartate transport that was not mediated by protein kinase C. Blockade of store-operated calcium channels
with 2-aminoethoxydiphenyl borate (50 μM) or SKF 96365 (10 μM) caused a net inhibition of D-[3H]aspartate
uptake. Co-incubation of C6 glioma cells with both thapsigargin and 2-aminoethoxydiphenyl borate (but not
SKF 96365) prevented the increase in D-[3H]aspartate transport that was observed in the presence of
thapsigargin alone. Furthermore, 2-aminoethoxydiphenyl borate, but not SKF 96365, reduced the increase in
intracellular calcium that occurred following pre-incubation of the cells with thapsigargin. It is concluded
that, in C6 glioma cells, stimulation of EAAC1-mediated glutamate transport by thapsigargin is dependent on
entry of calcium via the NSCC-1 subtype of store operated calcium channel and is mediated by protein
kinase C. In contrast, in the absence of store operated calcium entry, thapsigargin inhibits transport.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionFive members of the high afﬁnity glutamate transporter family
have been identiﬁed in the mammalian brain (for a review, see [1]). It
is generally agreed that three subtypes, namely GLAST (EAAT1 in the
human), GLT1 (EAAT2) and EAAC1 (EAAT3), together account for
almost all of the glutamate taken up into both pre-synaptic neurons
and glial cells (astrocytes). GLAST and GLT1 are principally astrocytic
carriers, whereas EAAC1 is generally associated with neurons [2–6].
The majority of synaptically released glutamate is cleared by GLT1-
and GLAST-mediated uptake into astrocytes, thereby preventing death
of neurones caused by hyperactivation of glutamate receptors
(‘excitotoxicity’). Paradoxically, the C6 glioma cell line, which is
derived from a rat astrocytoma, expresses only the EAAC1 transporter
subtype [7]. It has been proposed that insufﬁcient uptake of glutamate
in glioma cells may contribute to the progression of brain tumours,
because of damage to adjacent neurones through excitotoxic
mechanisms initiated by elevated extracellular glutamate [8].e; CaMKII, calcium-calmodulin
1; ER, endoplasmic reticulum;
ositol-3-kinase; PMA, phorbol
nel
53 1 2837211.
.
l rights reserved.Previous studies on the regulation of the EAAC1 transporter by
protein kinase C (PKC) have highlighted differences between the
response generated in C6 glioma cells [7,9,10] and in other experi-
mental models, including primary neuronal cultures [11] and stable
cell lines over-expressing the protein (HEKEAAC1 cells) [12]. Modula-
tion of PKC does not inﬂuence EAAC1-mediated transport of L-[3H]
glutamate in neurones [11,13] or in HEKEAAC1 cells [12], whereas in C6
glioma cells, the PKC activator, phorbol myristate-3-acetate (PMA)
increases both the transport of L-[3H]glutamate and the cell surface
expression of EAAC1 [9,14,15]. In contrast, the PI3K inhibitor,
wortmannin, invariably decreases glutamate transport in a range of
experimental systems, including C6 glioma cells, Xenopus oocytes
over-expressing EAAC1, neurone-enriched primary cultures, primary
cerebellar neurones and Bergmann glial cells [9,13,16,17]. PI3K is also
implicated in the stimulation of glutamate transport in primary
cerebellar neurones by minocycline [18].
These observations have led us to question whether it is
speciﬁcally calcium-dependent signalling pathways that are most
variable when comparing the modulation of glutamate transport in
C6 glioma cells to other experimental systems. There is currently no
data on how changes in cytosolic calcium speciﬁcally inﬂuence
EAAC1-mediated glutamate transport in C6 glioma cells. However, it
is known that endothelin, which activates two types of calcium-
permeable non-selective cation channel (NSCC-1 and NSCC-2) in C6
glioma cells, causes an increase in the uptake of glutamate and cell-
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type A receptors [19,20].
We have measured the effect of calcium modifying agents on D-
[3H]aspartate transport and calcium ﬂuxes in C6 glioma cells in an
effort to identify the origin of the responsiveness of EAAC1 to
calcium-dependent kinases. As predicted, we ﬁnd that the response
of C6 glioma cells to changes in intracellular calcium are at
variance to the results that have been reported for neuronal cells
expressing the EAAC1 transporter [11]. Depletion of endoplasmic
reticulum (ER) stores of calcium by the Ca2+ ATP pump inhibitor,
thapsigargin, causes a transient increase in D-[3H]aspartate trans-
port in C6 glioma cells that is dependent on store-operated calcium
entry from the cytosol. Furthermore, we provide evidence that, in
the absence of extracellular calcium, thapsigargin produces a net
inhibition of D-[3H]aspartate transport.
2. Materials and methods
2.1. Cell culture
C6 glioma cells were grown in Dulbecco's modiﬁed Eagle's
medium supplemented with 10% foetal bovine serum, penicillin/
streptomycin and L-glutamine (2 mM) on 100 mm diameter cell
culture Petri dishes at 37 °C in a humidiﬁed atmosphere of 5% CO2,
95% air. Cells were gown as a monolayer and routinely passaged
twice weekly.
2.2. Measurement of D-[3H]aspartate transport in C6 glioma cells
Measurements of the rate of D-[3H]aspartate uptake into C6
glioma cells were performed in 12-well plates. The cells were seeded
at a density of 0.25×106 cells into each well and, on reaching 80%
conﬂuency (typically 2–3 days), were used in the uptake assays. The
growth medium was removed by suction and the cells were
incubated with 450 μl Krebs' bicarbonate medium (contents in
mM: NaCl 109.6, KCl 4.72, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25,
glucose 11 and CaCl2 2.5 pH 7.4, gassed in 95% O2/5% CO2). The
transport assay was initiated by the addition of 50 μl D-[3H]aspartate
solution (ﬁnal concentration 10–500 μM; speciﬁc activity 296–
14,800 Bq/nmol, unless otherwise stated). Time-course experiments
established that transport of D-[3H]aspartate was linear with time
from 0–20 min (results not shown). Accordingly, transport of D-[3H]
aspartate into C6 glioma cells was determined for an incubation
period of 5 min at 37 °C. Thereafter, the medium was removed by
suction and the cell layer was washed twice with 500 μl Krebs'
bicarbonate medium. The cells were then solubilised overnight in
500 μl 0.5 M NaOH. An aliquot of 300 μl of the solubilised cells was
added to 5 ml scintillation cocktail (Ecoscint A) in a scintillation vial
and the level of radioactivity incorporated into the cells was
determined by liquid scintillation spectroscopy. The remaining
200 μl aliquot of solubilised cells was retained for protein
determination by the method of Bradford et al. [21]. The sodium
dependency of D-[3H]aspartate transport was assessed by using
sodium-free Krebs' medium (choline chloride substituted for NaCl
and 8.1 mM Tris used in place of NaHCO3 to bring the pH to 7.4). The
rate of sodium-dependent transport was calculated by subtraction of
the rate of sodium-independent transport from the rate of total
transport observed in the presence of sodium. All data are
represented as the sodium-dependent transport of D-[3H]aspartate,
unless otherwise stated. Calcium-free Krebs' medium contained
EGTA (0.98 mM) in place of calcium. Calcium-modifying agents and
kinase inhibitors/activators were typically added to the cell incuba-
tion medium for 15 min prior to the initiation of a D-[3H]aspartate
transport assay, unless otherwise stated. Preliminary experiments
established that each agent had no effect on sodium-independent
transport of D-[3H]aspartate and that the vehicle (1% DMSO) did notaffect the sodium-dependent uptake of D-[3H]aspartate in the
absence of test compound (results not shown).
2.3. Ratiometric measurement of intracellular [Ca2+] in C6 glioma cells by
confocal microscopy
Cells were seeded into 35 mm glass bottom culture dishes at a
density of 0.25×106 cells per dish in Dulbecco's modiﬁed Eagle's
medium supplemented with 10% foetal bovine serum, penicillin/
streptomycin and L-glutamine (2 mM). They were grown at 37 °C in a
humidiﬁed atmosphere of 5% CO2, 95% air until 60–75% conﬂuent.
Intracellular calcium levels were measured using two visible wave-
length calcium sensitive dyes, Fluo 3 and Fura Red. Fluo 3 exhibits an
increase in green ﬂuorescence upon binding to calcium, whereas Fura
Red exhibits a decrease in red ﬂuorescence upon binding to calcium.
The Fluo 3/Fura Red ratio is a good indicator of intracellular calcium
levels [22]. Initially, cells were loaded with the calcium sensitive dyes
by incubation with 3 μM Fluo 3 and 3 μM Fura Red acetoxymethyl
esters for 1 h in Ca2+/Mg2+PBS buffer at 37 °C. The dye was removed,
and the culture washed with Ca2+/Mg2+PBS buffer. Subsequently, the
cultures were washed three times with buffer. Fluo 3 and Fura Red
were excited at 488 nm, and ﬂuorescence emissions at 525 nm and
660 nm were recorded simultaneously using a Carl Zeiss LSM 510
UVMETA confocal microscope. The culture was scanned for 30 s to
determine a base line prior to exposure to calcium modifying agents.
Frames of 256×256 pixels were taken and the pinhole diameter
was kept constant. The ratio of the ﬂuorescence of the two dyes was
calculated according to the equation: R=emission 505–535 nm
(Fluo-3)/emission N560 nm (Fura Red). Plots were constructed
showing ﬂuorescence ratio on the ordinate against time on the
abscissa. For each treatment, 15 cells were analysed in three
independent determinations.
2.4. Measurement of cell-surface expression of EAAC1 by
biotinylation assay
EAAC1 cell surface expression was measured as previously
described [9] with minor modiﬁcations. C6 glioma cells were seeded
in 10 cm dishes and allowed to reach 80% conﬂuency. Plates were
then rinsed twice with ice-cold PBS containing 0.1 mM Ca2+ and
1.0 mM Mg2+ (PBS Ca2+/Mg2+) followed by incubation in 2 ml biotin
solution (sulfo-NHS-biotin, 1 mg/ml in PBS Ca2+/Mg2+) for 30 min at
4 °C with gentle agitation. After two rinses with PBS Ca2+/Mg2+
containing 100 mM glycine, plates were incubated in 100 mM
glycine for 30 min at 4 °C to quench unreacted biotin. Cells were
lysed in RIPA buffer (100 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM
EDTA, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate containing
protease inhibitors) for 1 h at 4 °C. After scraping, lysates were
cleared of cell debris by centrifugation at 130,000 rcf for 20 min. An
aliquot of cell lysate was saved and mixed with an equal volume of
4× Laemmli buffer (240 mM Tris–HCl, pH 6.8, 8% SDS, 4%
2-mercaptoethanol) for further analysis as the “total protein”
fraction. A second aliquot of cell lysate was incubated with an
equal volume of avidin-conjugated beads. After overnight incubation
at 4 °C, supernatant containing non-biotinylated proteins (“intracel-
lular protein” fraction) was recovered by centrifugation at 130,000
rcf for 15 min and mixed with an equivalent volume of 4× Laemmli
buffer. Beads containing the biotinylated (“cell surface protein”)
fraction were washed once with RIPA buffer containing protease
inhibitors, twice with a high salt buffer (50 mM Tris, 5 mM EDTA,
500 mM NaCl, 0.1% Triton X-100, pH 7.5), and twice with a no salt
buffer (50 mM Tris, pH 7.5). Finally, beads were incubated with 2×
Laemmli buffer (120 mM Tris–HCl, pH 6.8, 4% SDS, 2% 2-mercap-
toethanol) for 30 min at 37 °C and then centrifuged at 130,000 rcf for
15 min. The supernatant containing biotinylated proteins was saved
for further analysis. Fractions were stored at −20 °C. The amount of
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kit using the Bradford method. For Western blot analysis, approxi-
mately 20 μg protein was loaded on 10% gels, and transferred onto a
nitrocellulose membrane. Blots were incubated in anti-EAAC1 (1:500)
or anti-actin (1:1000), and visualised with chemiluminescence.
2.5. Data analysis
Transport experiments were conducted under conditions of
initial velocity and the rate curves were calculated by non-linear
regression analysis by applying the Michaelis Menten equation to
the data using the Kaleidagraph® Application from Synergy Soft-
ware. Kinetic data were not corrected to allow for diffusion. The
results in each ﬁgure are expressed as the mean±S.E.M. of the
number of observations indicated. Data were analysed by Student's
unpaired t-test (⁎). Where more than two comparisons were being
made, the Tukey analysis of variance (δ) was used. In each case, the
difference between means was considered signiﬁcant at P values of
less than 0.05.
2.6. Materials
SKF 96365, thapsigargin, anti-rabbit secondary antibody and all
RIPA buffer components, unless indicated otherwise, were purchased
from Sigma-Aldrich, Dorset, UK; protease inhibitors were purchased
from Roche, Dublin, Ireland. 2-APB was from Tocris, Avon, UK; PMA,
Bis-X, H-89, KN-93, wortmannin and genistein were all supplied by
Merck Biosciences, U.K. Fura Red (AM) and Fluo-3 were obtained from
Invitrogen/Molecular Probes, Eugene, OR, U.S.A. and were dissolved in
DMSO (3%, giving a ﬁnal concentration of DMSO in each assay of
0.06%) prior to use. Rabbit anti-rat EAAC1 primary antiserum was
obtained from Alpha Diagnostic International, TX, USA. Sulfo-NHS-
biotin and UltraLink Immobilized Monomeric Avidin beads were
obtained from Pierce (Rockford, IL, USA). 35 mm glass bottom culture
dishes were obtained from MatTek Corporation, MA, U.S.A.Fig. 1. Calcium signals evoked by thapsigargin in C6 glioma cells. Cells were pre-loaded with
the following conditions: (A) thapsigargin alone; (B) thapsigargin in the presence or absen
thapsigargin in the presence or absence of 50 μM2-APB. Fluorescence measurements were m
SEM of 41–56 single cell traces from 3 separate experiments. TG, thapsigargin; SKF, SKF 9633. Results
3.1. Thapsigargin stimulates store-operated entry of calcium into C6
glioma cells
Following loading with Fura Red and Fluo-3, C6 glioma cells were
incubated in the presence of 10 μM thapsigargin under the following
conditions: thapsigargin alone, thapsigargin and zero calcium,
thapsigargin and 10 μM SKF 96365, thapsigargin and 50 μM 2-APB
(Fig.1A–D). A large increase in intracellular calcium (as indicated by an
increase in Fluo-3 λem/Fura Red λem) was observed following
incubation of the cells with thapsigargin, which was abolished by
either removal of extracellular calcium or co-incubation of the cells
with 2-APB. In contrast, co-incubation of the cells with thapsigargin
and SKF96363 showed a smaller increase in calcium (Fig. 1C).
3.2. Pre-incubation of C6 glioma cells with thapsigargin stimulates
sodium-dependent D-[3H]aspartate transport
Pre-incubation of cells with 10 μM thapsigargin for 0–40 min
prior to initiation of a transport assay showed a signiﬁcant increase
in the sodium-dependent uptake of 50 μM D-[3H]aspartate, which
reached a peak at 15 min, but had returned to control values by
30 min (Fig. 2). Sodium-independent uptake of D-[3H]aspartate was
not affected by pre-incubation of C6 glioma cells in the presence of
10 μM thapsigargin at any of the time points tested (results not
shown). Kinetic analysis of sodium-dependent D-[3H]aspartate
uptake by C6 glioma cells following a 15-min pre-incubation
with 10 μM thapsigargin showed a signiﬁcant increase (185% of
control; Pb0.001) in the maximum rate (Vmax) of transport from
0.592±0.066 nmol/mg protein/min in cells incubated in the absence
of thapsigargin to 1.10±0.02 nmol/mg protein/min in its presence
(Fig. 3). No signiﬁcant change in the KM was observed (36±15 μM in
control, compared to 53±3 μM following pre-incubation of the cells
with 10 μM thapsigargin). Cell surface expression of EAAC1 increased3 μM Fura Red AM and 3 μM Fluo-3 and were incubated with 10 μM thapsigargin under
ce of calcium; (C) thapsigargin in the presence or absence of 100 μM SKF 96365; (D)
ade for 0–10min following addition of each compound. The plots shown are the mean±
65.
Fig. 3. Thapsigargin-induced changes in functional activity and expression of EAAC1 in
C6 glioma cells. (A) Sodium-dependent transport of D-[3H]aspartate (10 – 500 μM) was
determined in C6 glioma cells in both the presence (○) or absence (●) of 10 μM
thapsigargin for a pre-incubation period of 15 min prior to initiation of the transport
assay. The results are the mean±SEM of at least 3 separate determinations measured in
triplicate. (B) Cells were incubated in the absence (clear bars) or presence (shaded bars)
of 10 μM thapsigargin for 15 min and expression of EAAC1 was determined using a
membrane impermeant biotinylation assay. (i) Summary of four independent
experiments (mean±SEM), presented as the sum of both monomers (75 kD) and
multimers (175 kD) and expressed as the percentage of the control in total lysate, cell
surface and intracellular protein fractions. (ii) Representative Western blot of EAAC1
and actin expression in each fraction. ⁎Pb0.05, Students unpaired t-test.
Fig. 2. Time course of the pre-incubation of C6 glioma cells with thapsigargin. C6
glioma cells were pre-incubated in the presence (○) or absence (●) of 10 μM
thapsigargin for 0–40 min prior to measurement of sodium-dependent transport of
50 μM D-[3H]aspartate for 5 min at 37 °C. The results are expressed as the % of
transport occurring in the absence of thapsigargin and are the mean±SEM of at least 3
separate determinations, each measured in triplicate. ⁎ Pb0.01, compared to transport
in the absence of thapsigargin.
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determined by densitometric analysis of Western blots of biotin-
labelled protein.
3.3. Stimulation of D-[3H]aspartate transport in C6 glioma cells by
phorbol myristate-3-acetate
Pre-incubation of cells with 100 nM phorbol myristate-3-acetate
(PMA) for 15 min prior to measurement of sodium-dependent D-
[3H]aspartate uptake led to a signiﬁcant increase in the Vmax of
transport from 0.642±0.052 nmol/mg protein/min in controls to
1.22±0.09 nmol/mg protein/min in the presence of PMA (190% of
control; Pb0.01; Fig. 4). There was no change in the KM observed
in the presence of PMA (56±12 μM) compared to its absence
(43±12 μM).
3.4. Removal of extracellular calcium abolishes the stimulation of D-[3H]
aspartate transport in C6 glioma cells by thapsigargin, but not phorbol
myristate-3-acetate
Cells were pre-incubated with thapsigargin (10 μM) in calcium-
free Krebs' bicarbonate medium for 30 min prior to measurement
of the uptake of 1–300 μM D-[3H]aspartate. In separate experi-
ments, cells were pre-incubated with 100 nM PMA for 30 min
prior to measurement of the uptake of 50 μM D-[3H]aspartate. In
both sets of experiments, control cells were pre-incubated in
calcium-free Krebs' bicarbonate medium for 30 min before
initiation of the transport assay.
In the absence of extracellular calcium, thapsigargin caused a
further reduction in the rate of transport that was observed in the
absence of calcium alone. Removal of extracellular calcium caused a
reduction in the Vmax of D-[3H]aspartate transport from 0.512
±0.036 nmol/mg protein/min in control cells to 0.345±0.017 nmol/
mg protein/min without calcium (67% of control; Pb0.05). Pre-
incubation of the cells with thapsigargin caused a further drop in
the Vmax of transport to 0.235±0.010 nmol/mg protein/min (46% of
control; Pb0.01; Fig. 5A). There was no signiﬁcant difference in the KM
values of D-[3H]aspartate transport under these conditions: 41±10 μM
(control), compared to 66±9 μM (calcium-free) and 66±5 μM
(calcium-free with thapsigargin). The stimulation in 50 μM D-[3H]
aspartate uptake by PMA persisted in the absence of extracellular
calcium (Fig. 5B).3.5. Inhibition of protein kinase C blocks the stimulation of D-[3H]
aspartate transport by thapsigargin in C6 glioma cells
Pre-incubation of cells in the presence of both thapsigargin (10 μM)
and the protein kinase C inhibitor, bisindolylmaleimide (Bis-X; 1 μM)
for 15 min prior to measurement of D-[3H]aspartate (50 μM) transport
Fig. 5. Calcium-dependency of the stimulation of D-[3H]aspartate transport in C6 glioma
cells by thapsigargin and phorbol myristate-3 acetate. (A) Sodium-dependent transport
of D-[3H]aspartate (1–300 μM) was determined in both normal (●) and calcium-free
Krebs' medium either with (⋄) or without (○) prior incubation of the cells with 10 μM
thapsigargin. (B) Transport of 50 μM D-[3H]aspartate was determined in both normal
and calcium-free Krebs' medium either with or without pre-incubation with 100 nM
PMA. The results in (B) are expressed as the percentage of transport that occurred in
normal Krebs' medium in the absence of PMA. All data are the mean±SEM of at least 3
separate determinations, each measured in triplicate. δPb0.05.
Fig. 4. Kinetic analysis of D-[3H]aspartate transport in C6 glioma cells in the presence
of phorbol myristate-3-acetate. Sodium-dependent transport of D-[3H]aspartate
(10–500 μM) was determined in C6 glioma cells in both the presence (○) or absence
(●) of 100 nM PMA for a pre-incubation period of 15 min prior to initiation of the
transport assay. The results are the mean±SEM of at least 3 separate determinations
measured in triplicate.
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presence of thapsigargin alone (180±5% of control with thapsigargin
alone, compared to 106±12% of control with both thapsigargin and
Bis-X; Pb0.05). Pre-incubation of C6 glioma cells in with either the
protein kinase A inhibitor, H-89 (10 μM) or the CaM kinase II inhibitor,
KN-93 (8 μM) for 15 min in the presence of 10 μM thapsigargin had no
effect on the stimulation of 50 μM D-[3H]aspartate transport observed
in the presence of thapsigargin alone (Fig. 6). None of the inhibitors
tested had any effect on transport of D-[3H]aspartate in the cells in the
absence of thapsigargin. Bis-X had no effect on the decrease in
transport by thapsigargin observed in the absence of calcium (results
not shown).
3.6. Blockade of store-operated calcium channels inhibits transport of
D-[3H]aspartate in C6 glioma cells
2-aminoethoxydiphenyl borate (2-APB) is a non-selective inhibitor
of store-operated calcium channels (SOCCS) [23] and SKF 96365
speciﬁcally blocks the NSCC-2 subtype of SOCC [24,25]. Either 2-APB
(50 μM) or SKF 96365 (10 μM) were added to the incubation medium
for 20 min and 1 h, respectively, before initiation of a transport assay.
Both compounds signiﬁcantly decreased uptake of D-[3H]aspartate
(50 μM) in the absence of thapsigargin (53±4% of control with 2-APB
and 66±3% of control with SKF 96365; Fig. 7). No stimulation in D-[3H]
aspartate uptake by thapsigargin was observed when the cells were
co-incubated with 2-APB and thapsigargin for 20 min prior to the
transport assay (Fig. 7A). In contrast, the stimulation in D-[3H]
aspartate (50 μM) transport arising from pre-incubation of the cells
with 10 μM thapsigargin persisted when the cells were incubated with
10 μM SKF 96365 for 60 min before the addition of thapsigargin
(96±5% of control; Fig. 7B). It is concluded that the stimulation of
transport by thapsigargin is dependent on entry of calcium via the
NSCC-1 subtype of SOCC.
4. Discussion
This study provides important information on the responsiveness
of C6 glioma cells to calcium-modifying agents and on the
relationship between intracellular calcium and the functionalactivity and cell surface expression of the EAAC1 glutamate
transporter in these cells.
As an inhibitor of the endoplasmic reticulum Ca2+-ATPase,
thapsigargin is a widely used tool for depletion of ER calcium stores
and consequent elevation of the intracellular calcium concentration.
As predicted, pre-incubation of C6 glioma cells with thapsigargin
produced a signiﬁcant increase in intracellular calcium that, apart
from the initial rise, was dependent on entry of calcium from the
extracellular medium. C6 glioma cells do not contain voltage-sensitive
calcium channels [26] and it follows that calcium entry must, in the
absence of receptor stimulation, occur by store-operated calcium
Fig. 7. The effect of SOC channel blockers on the stimulation of D-[3H]aspartate by
thapsigargin. C6 glioma cells were pre-incubated with either (A) 2-APB (50 μM, 20 min)
or (B) SKF 96365 (100 μM, 1 h) before measurement of sodium-dependent transport of
D-[3H]aspartate. In each case,10 μM thapsigarginwas included for the ﬁnal 15min of the
pre-incubation period. The results are expressed as the % of transport that occurred in
the presence of thapsigargin alone and are the mean±SEM of three separate
determinations, each measured in triplicate. δPb0.05, Neuman Keuls test.
Fig. 6. The effect of protein kinase inhibitors on the stimulation of D-[3H]aspartate
transport by thapsigargin in C6 glioma cells. Cells were pre-incubated with 10 μM
thapsigargin for 15 min prior to measurement of D-[3H]aspartate transport in both the
presence and absence of Bis-X (10 μM), H-89 (10 μM) or KN-93 (8 μM). The results are
expressed as the percentage of transport observed in the absence of thapsigargin or
inhibitors and are themean±SEM of at least 3 independent determinationsmeasured in
triplicate. ⁎Pb0.05, Student's t-test; δPb0.05, Neuman Keuls test.
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(NSCC-1 and NSCC-2) [19]. SKF96395 inhibits NSCC-2 but not NSCC-1,
whereas 2-APB is a non-selective inhibitor of both channels
[23–25,27]. Therefore, since 2-APB inhibited the thapsigargin-
mediated rise in intracellular calcium, whereas SKF 96365 did not, it
is concluded that the increase in intracellular calcium occurs via the
NSCC-1 subtype of SOCC in C6 glioma cells.
Pre-incubation of C6 glioma cells with thapsigargin signiﬁcantly
increased the rate of D-[3H]aspartate transport, implying that a rise
in intracellular calcium stimulates the EAAC1 transporter. The fact
that the PKC inhibitor, Bis-X, blocked the stimulatory effect of
thapsigargin and that incubation of the cells with PMA also
increased transport, strongly suggests that the increase in transport
observed with thapsigargin was mediated by PKC. These results are
in agreement with other studies that have shown stimulation of
EAAC1 by PKC in C6 glioma cells [14,15]. The increased cell surface
expression of EAAC1 at the cell membrane following incubation of
the cells with thapsigargin indicates that the observed increase in
transport is due to increased delivery of the transporter to the
plasma membrane. This result is in agreement with Bianchi et al.
[14], who demonstrated an increase in cell surface expression of
EAAC1 in C6 glioma cells by PKC. This group described the increased
trafﬁcking of EAAC1 to the membrane in response to PKC activation
by phorbol esters as a ‘peculiar feature of EAAC1’ because PKC down-
regulates the cell surface expression of the other major glutamate
transporters, EAAT1 (GLAST) and EAAT2 (GLT1) [13].
A reduction in transport of D-aspartate was observed following
incubation of C6 cells in either calcium free medium or in the
presence of 2-APB. The 60% decrease in the Vmax in EAAC1-mediated
transport of glutamate in the absence of extracellular calcium is
comparable to the reduced Vmax recorded in two independent
studies of the calcium-dependency of glutamate uptake in synapto-
somes [28,29]. The conclusion in all cases is that extracellular
calcium is required for optimal transport of glutamate. According to
Mafra et al. [29], the reduced uptake of glutamate was not due to a
de-stabilisation of membrane proteins caused by absence of calcium.
One possibility may be that the decrease in uptake in calcium-free
media may have been caused by partial activation of voltage-
sensitive sodium channels, leading to a reduction in the sodiumgradient required to drive the inward transfer of glutamate. We have
not tested this directly, but note that tetrodotoxin reversed the
reduction in transport in the absence of calcium in synaptosomes
[28]. Another possible explanation, arising from our observation that
2-APB on its own reduced uptake of D-[3H]aspartate is that entry of
calcium from ‘constitutively-active’ calcium channels exerts a
positive regulatory effect on EAAC1 in C6 cells, but the mechanism
by which this might occur is not currently known. Our experiments
suggest that it does not involve PKA, PKC, or CaMKII.
Removal of extracellular calcium or blockade of store-operated
calcium entry by 2-APB in C6 glioma cells changed the response to
thapsigargin from stimulation to net inhibition of D-[3H]aspartate
transport. The reduction in transport was kinase independent, since
inhibitors of PKC, PKA or CaMKII had no effect on the decrease in
transport by thapsigargin observed in calcium-free media. In the
absence of extracellular calcium, therefore, thapsigargin produces
the same effect in C6 glioma cells as it does in neuronal cultures
expressing EAAC1 [11,30] and in primary astrocytes expressing
GLAST [31]. The inhibitory pathway is kinase independent in
557A. Murphy et al. / Biochimica et Biophysica Acta 1788 (2009) 551–558neuronal cultures expressing EAAC1 and, unlike C6 cells, transport
of glutamate is completely unaffected by PMA-induced stimulation
of PKC [11].
We believe that C6 glioma cells are capable of two separate
responses to the emptying of intracellular calcium stores by
thapsigargin: one stimulatory, which requires entry of calcium
from the extracellular medium, the other, inhibitory, which does
not.We propose that in neuronal cells, such as were used in the study
by Yang et al. [11], only the inhibitory pathway exists. Blockade of the
thapsigargin-mediated stimulation of D-[3H]aspartate transport and
calcium inﬂux by 2-APB, deemed a ‘reliable blocker of store-operated
calcium entry’ [23], supports the theory of calcium entry from the
extracellular medium as the crucial factor in determining whether
thapsigargin stimulates, rather than inhibits, D-[3H]aspartate trans-
port in C6 glioma cells. The fact that the stimulation of D-[3H]
aspartate transport by thapsigargin persisted in the presence of SKF
96365 supports our view that calcium entry following depletion of ER
stores is mediated by NSCC-1, but not NSCC-2. Absolute proof would
require a selective inhibitor for NSCC-1, which is not currently
available. The molecular link-up between store-operated calcium
entry and the EAAC1 transporter requires further investigation. Both
thapsigargin-mediated inﬂux of calcium and PKC-dependent stimu-
lation of EAAC1 do not require integrity of the actin cytoskeleton
[14,32]. It is believed that a diffusiblemessenger forms a link between
calcium stores and the plasma membrane calcium channels in the
case of thapsigargin, whereas activation of purinergic receptors, for
example, promotes a direct link-up between the calcium stores and
the plasmamembrane [32]. Other stimulators of EAAC1 activity in C6
glioma cells, such as endothelin-1 [20], increase cytoskeletal-
dependent cell surface expression of the protein, which points to
the existence of at least two pools of the EAAC1 transporter in C6
glioma cells— one that is linked to the cytoskeleton and another that
is not.
In summary, these results have shown that store-operated
calcium entry in C6 glioma cells stimulates EAAC1-mediated
transport. Since C6 glioma cells are derived from a tumour cell
line, the pathological relevance of this work needs to be considered.
Astrocytoma and glioblastoma cell lines frequently differ from
normal astrocytes in terms of their capacity for glutamate transport.
The results presented in this report show that the responsiveness of
glutamate transporters in C6 glioma cells to changes in intracellular
calcium are also at variance with non tumour cells and suggest that
it is not the calcium stores themselves, but rather store-operated
calcium entry that ultimately controls transport. Further work needs
to be directed towards understanding how the absence of a fully
regulated glutamate transport system threatens glutamate home-
ostasis leading to glutamate-mediated cytotoxicity. Such knowledge
would be instrumental to the development of strategies aimed at
augmenting glutamate uptake in the diseased brain.
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